{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:34:25Z","timestamp":1788870865473,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":3019,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-102035"],"award-info":[{"award-number":["HL-102035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-68138"],"award-info":[{"award-number":["HL-68138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Children's Research Institute Funds"},{"name":"Midwest Athletes against Childhood Cancer Fund"},{"name":"Rebecca Slye Endowment Fund"},{"name":"National Hemophilia Foundation JGP Postdoctoral Research Fellowship"},{"name":"American Heart Association Award from the Greater Midwest Affiliate","award":["0755827Z"],"award-info":[{"award-number":["0755827Z"]}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/jth.12633","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T19:02:02Z","timestamp":1402945322000},"page":"1283-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection"],"prefix":"10.1016","volume":"12","author":[{"given":"J.A.","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12633_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2003-37945","article-title":"Gene transfer as an approach to treating hemophilia","volume":"29","author":"High","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl. 1","key":"10.1111\/jth.12633_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2011.04369.x","article-title":"Gene therapy for haemophilia: a long and winding road","volume":"9","author":"High","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/mt.2011.13","article-title":"Hemophilia gene therapy: a Holy Grail found","volume":"19","author":"Ponder","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1566523033347417","article-title":"Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A","volume":"3","author":"Saenko","year":"2003","journal-title":"Curr Gene Ther"},{"key":"10.1111\/jth.12633_bb0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","article-title":"Sustained high\u2010level expression of full\u2010length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector","volume":"95","author":"Balague","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0035","first-page":"690","article-title":"High level expression of human factor VIII in mammalian cells after retroviral\u2010mediated gene transfer","volume":"114","author":"Guo","year":"2001","journal-title":"Chin Med J (Engl)"},{"key":"10.1111\/jth.12633_bb0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0045","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/sj.gt.3302093","article-title":"Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction","volume":"10","author":"Tiede","year":"2003","journal-title":"Gene Ther"},{"key":"10.1111\/jth.12633_bb0050","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ymthe.2005.09.007","article-title":"Correction of murine hemophilia A by hematopoietic stem cell gene therapy","volume":"12","author":"Moayeri","year":"2005","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymthe.2004.04.009","article-title":"Naked DNA transfer of Factor VIII induced transgene\u2010specific, species\u2010independent immune response in hemophilia A mice","volume":"10","author":"Ye","year":"2004","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0060","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver\u2010directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.12633_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/hum.2006.17.46","article-title":"Efficient AAV1\u2010AAV2 hybrid vector for gene therapy of hemophilia","volume":"17","author":"Hauck","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1111\/jth.12633_bb0070","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1538-7836.2007.02629.x","article-title":"High expression reduces an antibody response after neonatal gene therapy with B domain\u2010deleted human factor VIII in mice","volume":"5","author":"Xu","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0075","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"key":"10.1111\/jth.12633_bb0080","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood-2007-04-082602","article-title":"Hematopoietic stem\u2010cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens","volume":"110","author":"Ide","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/mt.2010.290","article-title":"A microRNA\u2010regulated and GP64\u2010pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A","volume":"19","author":"Matsui","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0090","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJM200106073442301","article-title":"Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A","volume":"344","author":"Roth","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12633_bb0095","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2003-01-0167","article-title":"Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion","volume":"102","author":"Powell","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2004-825638","article-title":"Clinical gene transfer studies for hemophilia A","volume":"30","author":"Chuah","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12633_bb0105","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI28416","article-title":"Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high\u2010titer inhibitory antibodies","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12633_bb0110","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2008-02-138214","article-title":"Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","article-title":"Lentivirus\u2010mediated platelet\u2010derived factor VIII gene therapy in murine haemophilia A","volume":"5","author":"Shi","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0120","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1538-7836.2012.04791.x","article-title":"Lentivirus\u2010mediated platelet gene therapy of murine hemophilia A with pre\u2010existing anti\u2010factor VIII immunity","volume":"10","author":"Kuether","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0125","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/ncomms3773","article-title":"Platelet\u2010targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A","volume":"4","author":"Du","year":"2013","journal-title":"Nat Commun"},{"key":"10.1111\/jth.12633_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2013-08-520478","article-title":"Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells","volume":"123","author":"Shi","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/76225","article-title":"Efficient retrovirus\u2010mediated transfer of the multidrug resistance 1 gene into autologous human long\u2010term repopulating hematopoietic stem cells","volume":"6","author":"Abonour","year":"2000","journal-title":"Nat Med"},{"key":"10.1111\/jth.12633_bb0140","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA\u2010SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1111\/jth.12633_bb0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/jth.12633_bb0150","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.1016394108","article-title":"Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3\u2010deficient dogs","volume":"108","author":"Fang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.12633_bb0155","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1538-7836.2004.00961.x","article-title":"Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX","volume":"2","author":"Shi","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha\u2010granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0037-1614124","article-title":"Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A","volume":"84","author":"Reipert","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0170","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-0037-1613094","article-title":"Long\u2010term persistence of anti\u2010factor VIII antibody\u2010secreting cells in hemophilic mice after treatment with human factor VIII","volume":"87","author":"Hausl","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12633_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2013.197","article-title":"Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice","volume":"22","author":"Chen","year":"2014","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0180","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/104303401753153947","article-title":"Systematic determination of the packaging limit of lentiviral vectors","volume":"12","author":"Kumar","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1111\/jth.12633_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/mt.2011.231","article-title":"Correction of Murine Bernard\u2010Soulier Syndrome by Lentivirus\u2010mediated Gene Therapy","volume":"20","author":"Kanaji","year":"2012","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0190","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/S0021-9258(18)68793-9","article-title":"Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells","volume":"263","author":"Kaufman","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12633_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.1352414","article-title":"Selection of drug\u2010resistant bone marrow cells in vivo after retroviral transfer of human MDR1","volume":"257","author":"Sorrentino","year":"1992","journal-title":"Science"},{"key":"10.1111\/jth.12633_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.exphem.2007.11.009","article-title":"In vivo selection of hematopoietic stem cells transduced at a low multiplicity\u2010of\u2010infection with a foamy viral MGMT(P140K) vector","volume":"36","author":"Cai","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1111\/jth.12633_bb0205","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood-2003-05-1572","article-title":"Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors","volume":"103","author":"Persons","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0210","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2002.06.110","article-title":"Clinical relevance of MGMT in the treatment of cancer","volume":"20","author":"Gerson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.12633_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/mthe.2002.0571","article-title":"Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG\/BCNU and allows selection in vitro","volume":"5","author":"Zielske","year":"2002","journal-title":"Mol Ther"},{"key":"10.1111\/jth.12633_bb0220","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/blood-2003-03-0677","article-title":"Successful treatment of murine beta\u2010thalassemia using in vivo selection of genetically modified, drug\u2010resistant hematopoietic stem cells","volume":"102","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12633_bb0225","first-page":"1952","article-title":"In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene","volume":"119","author":"Larochelle","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12633_bb0230","doi-asserted-by":"crossref","first-page":"252953","DOI":"10.1155\/2011\/252953","article-title":"Differential Secondary Reconstitution of In Vivo\u2010Selected Human SCID\u2010Repopulating Cells in NOD\/SCID versus NOD\/SCID\/gamma chain Mice","volume":"2011","author":"Cai","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1111\/jth.12633_bb0235","doi-asserted-by":"crossref","first-page":"133ra57","DOI":"10.1126\/scitranslmed.3003425","article-title":"Extended survival of glioblastoma patients after chemoprotective HSC gene therapy","volume":"4","author":"Adair","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1111\/jth.12633_bb0240","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1182\/blood-2008-10-186684","article-title":"Amelioration of murine beta\u2010thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma\u2010globin and the MGMT drug\u2010resistance gene","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12633","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622040181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622040181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12633\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:09:02Z","timestamp":1761534542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622040181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1538783622040181"],"URL":"https:\/\/doi.org\/10.1111\/jth.12633","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}